Gastroenterology and General Medical Trials

We have particular specialisation in gastroenterology clinical trials which include rare conditions that would be difficult and very time-intensive to capture through the usual university or public health system processes. Carrying out such trials can be extremely resource intensive and Sydney Clinical Trials has been established to provide access to clinical trials for this group. This is very helpful for both our sponsors and for our participants who are seeking to access clinical trials as an integral part of clinical service provision for improved patient outcomes.

No trials available

Forte Biosciences Clinical Study

This study is to test the safety and effectiveness of FB102 in well-controlled coeliac disease (those on a strict gluten free diet) following a gluten consumption challenge.

Physical Condition

Male and female patients who are aged between 18 to 70 years, have biopsy confirmed asymptomatic Coeliac disease

Requirements

This clinical trial is being run at Sydney Clinical Trials.
We are no longer actively recruiting for this clinical study.

Eupraxia Pharmaceuticals Clinical Study

Do you have pain and difficulty with swallowing? You might be eligible to participate in a clinical trial.

Eosinophilic Esophagitis (EoE) is a condition of the oesophagus (tube from your mouth to stomach) that can lead to difficulty swallowing and causing food to get stuck in your throat while swallowing. A type of white blood cell, called an eosinophil, builds up in the lining of your oesophagus and causes inflammation. Eupraxia Pharmaceuticals is conducting a clinical study to test a new treatment called EP-104IAR which has been formulated as an injection into the oesophagus aimed to help those experiencing these symptoms of EoE.

Physical Condition

Male and female patients of age 18 years to 75 years old who have been diagnosed with Eosinophilic Esophagitis and have active symptoms of Eosinophilic Esophagitis.

Requirements

There is no cost to participate.
This clinical trial is being run at Sydney Clinical Trials.

Daisy Chugai Clinical Study

Have you been diagnosed with Coeliac disease and still experience symptoms despite being on a gluten-free diet?

The aim of the study is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD)

Physical Condition

Male and female patients aged 18 to 75 years who have a biopsy- and blood test-confirmed diagnosis of Coeliac disease and experience symptoms despite attempting a gluten-free diet for at least 1 year

Requirements

There is no cost to participate.
This clinical trial is being run at Sydney Clinical Trials.